Paradigm Capital has initiated coverage on Medicago with a BUY and 1.5$

development & production

Commercialization of protein-based vaccines & biopharmaceuticals

Reply New Message

Prev Message Back To Forum Threaded View Next Message

MakingMoneyNow

Rank: President [?]

Points: 9119 [?]

Votes: 72 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Paradigm Capital has initiated coverage on Medicago with a BUY and 1.5$

in response to

Re: BNN interview w/Pierre Jeanniot/Chairman of Foundation on Antivirals

MakingMoneyNow

posted on Oct 14, 2009 05:36PM

Good Afternoon Everyone,

Paradigm Capital (www.paradigmcap.com) has initiated coverage on Medicago with a BUY rating and a target of $1.50.

Highlights:

-Company has technology to produce flu vaccines 6x faster than traditional companies

-Commercial agreements already in place (France, Saudi Arabia, India)

-Vaccine industry to grow from US$3.5b in 2007 to more than US$10b by 2015.

MMN

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply